By Marie Rosenthal, MS
The Advisory Committee on Immunization Practices (ACIP) recommended the use of the Ebola virus vaccine for certain U.S. residents who have an occupational risk for exposure to the Ebola Zaire strain.
In December, the FDA approved the recombinant vesicular stomatitis virus with substituted envelope glycoprotein of the Zaire ebolavirus (rVSV?G-ZEBOV-GP) vaccine (Ebola Zaire vaccine, live; Ervebo, Merck).